JP2025513593A5 - - Google Patents
Info
- Publication number
- JP2025513593A5 JP2025513593A5 JP2024563065A JP2024563065A JP2025513593A5 JP 2025513593 A5 JP2025513593 A5 JP 2025513593A5 JP 2024563065 A JP2024563065 A JP 2024563065A JP 2024563065 A JP2024563065 A JP 2024563065A JP 2025513593 A5 JP2025513593 A5 JP 2025513593A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- aforementioned
- cdr3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2022/089391 | 2022-04-26 | ||
| CN2022089391 | 2022-04-26 | ||
| PCT/CN2023/090822 WO2023208034A1 (en) | 2022-04-26 | 2023-04-26 | Anti-b7-h3 antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513593A JP2025513593A (ja) | 2025-04-24 |
| JP2025513593A5 true JP2025513593A5 (enExample) | 2026-05-11 |
Family
ID=88517776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024563065A Pending JP2025513593A (ja) | 2022-04-26 | 2023-04-26 | 抗ｂ７－ｈ３抗体およびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250313632A1 (enExample) |
| EP (1) | EP4514853A1 (enExample) |
| JP (1) | JP2025513593A (enExample) |
| CN (1) | CN119451988B (enExample) |
| WO (1) | WO2023208034A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025087323A1 (zh) * | 2023-10-25 | 2025-05-01 | 上海美雅珂生物技术有限责任公司 | B7-h3抗体药物偶联物及其应用 |
| WO2025245264A1 (en) * | 2024-05-21 | 2025-11-27 | Briapro Therapeutics Corp. | Anti-b7-h3 antibodies and methods of use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110305213B (zh) * | 2018-11-09 | 2023-03-10 | 泰州复旦张江药业有限公司 | 一种抗b7-h3抗体及其制备方法、其偶联物和应用 |
| US12312406B2 (en) * | 2018-11-09 | 2025-05-27 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Anti-B7-H3 antibody, preparation method therefor, conjugate and application thereof |
| AU2018449846B2 (en) * | 2018-11-22 | 2023-12-14 | Beijing Kanova Biopharmaceutical Co., Ltd. | An anti-B7-H3 antibody |
| CN109912718B (zh) * | 2019-03-20 | 2020-12-11 | 北京善科生物科技有限公司 | B7-h3抗原结合结构域的分离的结合蛋白、核酸、载体、car-t细胞及其应用 |
| CN113527487A (zh) * | 2020-04-22 | 2021-10-22 | 复星凯特生物科技有限公司 | 抗人b7-h3的单克隆抗体及其应用 |
| CN111944050B (zh) * | 2020-08-19 | 2022-05-13 | 苏州普乐康医药科技有限公司 | 一种抗b7-h3抗体及其应用 |
| JP7840955B2 (ja) * | 2020-12-02 | 2026-04-06 | ▲邁▼威（上海）生物科技股▲フン▼有限公司 | 抗ヒトｂ７－ｈ３抗体及びその利用 |
-
2023
- 2023-04-26 EP EP23795466.4A patent/EP4514853A1/en active Pending
- 2023-04-26 CN CN202380049914.4A patent/CN119451988B/zh active Active
- 2023-04-26 JP JP2024563065A patent/JP2025513593A/ja active Pending
- 2023-04-26 US US18/860,545 patent/US20250313632A1/en active Pending
- 2023-04-26 WO PCT/CN2023/090822 patent/WO2023208034A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024537323A5 (enExample) | ||
| JP2023511774A5 (enExample) | ||
| EP3645742B1 (en) | Anti-ror1 antibodies and methods of making and using thereof | |
| Hong et al. | Chemoenzymatic Synthesis of a Rhamnose‐Functionalized Bispecific Nanobody as a Bispecific Antibody Mimic for Cancer Immunotherapy | |
| JP2023535073A5 (enExample) | ||
| JP2022553922A5 (enExample) | ||
| JP2022513420A5 (enExample) | ||
| JP2017532952A5 (enExample) | ||
| JP2022533418A5 (enExample) | ||
| JP2023549537A5 (enExample) | ||
| RU2020113027A (ru) | Axl-специфичные антитела и их применения | |
| RU2020103344A (ru) | Конъюгаты антител с лекарственными средствами, характеризующиеся высокой in vivo переносимостью | |
| HRP20120701T1 (hr) | Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1 | |
| CN114502591A (zh) | 靶向bcma的抗体、双特异性抗体及其用途 | |
| JP2024501894A5 (enExample) | ||
| JP2023531185A5 (enExample) | ||
| CN117024592B (zh) | 抗b7h3抗体及其用途 | |
| CN118076387A (zh) | 靶向表达cdh17的肿瘤的多特异性抗体及其制备和使用方法 | |
| JP2024504390A5 (enExample) | ||
| JP2020534012A5 (enExample) | ||
| JP2023544143A5 (enExample) | ||
| JP2024001073A5 (enExample) | ||
| JP7851684B2 (ja) | Ｅｍｔ経路を遮断してがん幹細胞を克服するｉｌ８ | |
| JP2025512953A5 (enExample) | ||
| JP7738914B2 (ja) | ＴｒｉＡｘ抗体の組成、その製造方法及び使用方法 |